CSA
ABBV icon

Cornerstone Select Advisors’s AbbVie ABBV Stock Holding History

Cornerstone Select Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.45M Buy
11,249
+328
+3% +$72.8K 1.53% 20
2025
Q4 		$2.5M Buy
10,921
+34
+0.3% +$7.75K 1.73% 14
2025
Q3 		$2.52M Buy
10,887
+962
+10% +$196K 1.85% 13
2025
Q2 		$1.84M Sell
9,925
-653
-6% -$121K 1.62% 21
2025
Q1 		$2.22M Buy
10,578
+557
+6% +$108K 2.1% 10
2024
Q4 		$1.78M Buy
+10,021
New +$1.84M 1.72% 13

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cornerstone Select Advisors's ABBV Position: Q1 2026 in Review

Cornerstone Select Advisors increased its AbbVie (ABBV) stake by 3% in Q1 2026, buying an estimated $72.8K and bringing the position to 11,249 shares worth $2.45M. The position accounts for 1.53% of the portfolio, ranked #20.

Cornerstone Select Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.52M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cornerstone Select Advisors held 11,249 shares of AbbVie worth $2.45M as of Q1 2026.
  • Cornerstone Select Advisors bought 328 AbbVie shares in Q1 2026, an estimated $72.8K.
  • AbbVie made up 1.53% of Cornerstone Select Advisors's portfolio in Q1 2026, its #20 holding.
  • Cornerstone Select Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Cornerstone Select Advisors's AbbVie position peaked at $2.52M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cornerstone Select Advisors's 13F filing for Q1 2026, filed 13 May 2026.